| ERT | Enzyme replacement therapy |
| FD | Fabry disease |
| CMR | Cardiac magnetic resonance |
| LV | Left ventricular |
| FDCM | Fabry Disease Cardiomyopathy |
| GB-3 | Globotriaosylceramide |
| MWT | Maximal wall thickness |
| M6Pr | Mannose-6-phosphate receptors |
| ERT | Enzyme replacement therapy |
| FD | Fabry disease |
| CMR | Cardiac magnetic resonance |
| LV | Left ventricular |
| FDCM | Fabry Disease Cardiomyopathy |
| GB-3 | Globotriaosylceramide |
| MWT | Maximal wall thickness |
| M6Pr | Mannose-6-phosphate receptors |